Suppr超能文献

尿 CD80 在原发性肾病综合征复发中的预测性。

Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome.

机构信息

Department of Pediatric Nephrology, Children's Medical Center, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, China.

出版信息

Biomed Res Int. 2017;2017:9429314. doi: 10.1155/2017/9429314. Epub 2017 Aug 29.

Abstract

PURPOSE

The current study is aimed at investigating whether urinary CD80 is reliable to predict the recurrence of pediatric PNS.

MATERIALS AND METHODS

A total of 128 children, 105 males and 23 females, were enrolled in this study. Urinary samples were collected from SSNS and SRNS patients and 25 healthy children as controls. Urinary CD80 was measured by ELISA and adjusted for urinary creatinine excretion.

RESULTS

Urinary CD80 in relapse stage of SSNS was significantly higher, and the urinary CD80 of paired relapse and remission stages of each SSNS patient were also significantly different. No significant difference was found between the urinary CD80 in SRNS relapse group, SRNS remission group, and the control group. Similarly, there was no significant difference between frequent SSNS and not frequent SSNS in remission group, as well as the relapse group. There is no correlation between urinary CD80 and 24-hour urinary protein.

CONCLUSION

The increase of urinary CD80 was closely associated with the relapse of SSNS but was not related to the frequency of relapse. The urinary CD80 changes of concentration were reliable to predict the recurrence of SSNS. However, it cannot be used to predicate the frequent recurrence of PNS.

摘要

目的

本研究旨在探讨尿 CD80 是否可用于预测儿童 PNS 的复发。

材料与方法

共纳入 128 例患儿,男 105 例,女 23 例,其中 SSNS 患儿 75 例,SRNS 患儿 37 例,健康对照儿童 25 例。收集 SSNS 和 SRNS 患儿及健康对照儿童的尿样,采用 ELISA 法检测尿 CD80,并根据尿肌酐排泄进行校正。

结果

SSNS 缓解-复发期患儿尿 CD80 明显升高,且每位 SSNS 患儿缓解-复发期配对尿 CD80 差异均有统计学意义。SRNS 复发组、缓解组患儿尿 CD80 与对照组比较差异无统计学意义。同样,缓解期频繁复发与非频繁复发 SSNS 患儿间,以及复发组与缓解组间,尿 CD80 差异均无统计学意义。尿 CD80 与 24 小时尿蛋白定量无相关性。

结论

尿 CD80 浓度升高与 SSNS 复发密切相关,但与复发频率无关。尿 CD80 浓度变化可用于预测 SSNS 复发,但不能预测 PNS 的频繁复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0001/5603140/2a097b649867/BMRI2017-9429314.001.jpg

相似文献

1
Predictability of Urinary CD80 in the Relapse of Primary Nephrotic Syndrome.
Biomed Res Int. 2017;2017:9429314. doi: 10.1155/2017/9429314. Epub 2017 Aug 29.
4
Urinary annexin V in children with nephrotic syndrome: a new prognostic marker?
Pediatr Nephrol. 2008 Jan;23(1):79-82. doi: 10.1007/s00467-007-0606-z. Epub 2007 Nov 13.
5
Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome.
Front Immunol. 2022 Jan 31;12:801313. doi: 10.3389/fimmu.2021.801313. eCollection 2021.
6
The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
Sci Rep. 2018 Nov 23;8(1):17322. doi: 10.1038/s41598-018-35798-2.
8
Minimal change disease: a dysregulation of the podocyte CD80-CTLA-4 axis?
Pediatr Nephrol. 2014 Dec;29(12):2333-40. doi: 10.1007/s00467-014-2874-8. Epub 2014 Jul 14.
9
Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
Kidney Int. 2005 Jan;67(1):122-9. doi: 10.1111/j.1523-1755.2005.00062.x.

引用本文的文献

1
Urinary CD80 and Serum suPAR as Biomarkers of Glomerular Disease among Adults in Brazil.
Diagnostics (Basel). 2023 Jan 5;13(2):203. doi: 10.3390/diagnostics13020203.
2
CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.
Biomed Res Int. 2021 Jan 6;2021:6671552. doi: 10.1155/2021/6671552. eCollection 2021.
3
LPS-Treated Podocytes Polarize Naive CD4 T Cells into Th17 and Treg Cells.
Biomed Res Int. 2020 May 17;2020:8587923. doi: 10.1155/2020/8587923. eCollection 2020.
4
CTLA4-Ig Abatacept Ameliorates Proteinuria by Regulating Circulating Treg/IL-17 in Adriamycin-Induced Nephropathy Rats.
Biomed Res Int. 2020 Apr 25;2020:2347827. doi: 10.1155/2020/2347827. eCollection 2020.
5
The Search for Biomarkers to Aid in Diagnosis, Differentiation, and Prognosis of Childhood Idiopathic Nephrotic Syndrome.
Front Pediatr. 2019 Oct 16;7:404. doi: 10.3389/fped.2019.00404. eCollection 2019.

本文引用的文献

1
Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
Pediatr Nephrol. 2015 Feb;30(2):309-16. doi: 10.1007/s00467-014-2915-3. Epub 2014 Aug 21.
2
Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
Clin Nephrol. 2014 Mar;81(3):166-73. doi: 10.5414/CN108044.
3
Nephrotic syndrome.
Indian J Pediatr. 2012 Aug;79(8):1045-55. doi: 10.1007/s12098-012-0776-y. Epub 2012 May 30.
4
Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.
Nephrol Dial Transplant. 2012 Jan;27(1):81-9. doi: 10.1093/ndt/gfr271. Epub 2011 May 26.
5
Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome.
Clin Immunol. 2011 Jun;139(3):314-20. doi: 10.1016/j.clim.2011.02.018. Epub 2011 Mar 1.
6
Minimal change disease: a "two-hit" podocyte immune disorder?
Pediatr Nephrol. 2011 Apr;26(4):645-9. doi: 10.1007/s00467-010-1676-x. Epub 2010 Oct 30.
7
Maximal 'CD80-uria' with minimal change.
Kidney Int. 2010 Aug;78(3):236-8. doi: 10.1038/ki.2010.148.
8
Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Kidney Int. 2010 Aug;78(3):296-302. doi: 10.1038/ki.2010.143. Epub 2010 May 19.
9
The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome.
Pediatr Nephrol. 2009 Sep;24(9):1683-90. doi: 10.1007/s00467-009-1194-x. Epub 2009 Jun 5.
10
Urinary CD80 excretion increases in idiopathic minimal-change disease.
J Am Soc Nephrol. 2009 Feb;20(2):260-6. doi: 10.1681/ASN.2007080836. Epub 2008 Dec 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验